UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017458
Receipt number R000020071
Scientific Title Intensive surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma - A Prospective Multicenter Cohort Study
Date of disclosure of the study information 2015/05/08
Last modified on 2015/05/08 00:59:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intensive surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma - A Prospective Multicenter Cohort Study

Acronym

CHIBA NBI skill up study

Scientific Title

Intensive surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma - A Prospective Multicenter Cohort Study

Scientific Title:Acronym

CHIBA NBI skill up study

Region

Japan


Condition

Condition

Head and neck squamous cell carcinoma (HNSCC)

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to evaluate the usefulness of the training program about the endoscopic head and neck surveillance for beginner endoscopists.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Detection rate of histologically confirmed HNSCC

Key secondary outcomes

1) Quality of endoscopic images
2) Examination time
3) Positive predictive value (PPV) for diagnosis of HNSCC


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with histologically confirmed esophageal squamous cell carcinoma.
2) patients who recieve upper gastrointestinal endoscopy.
3) Patients who are at least 20 years of age.
4) Patients who have provided written informed consent.

Key exclusion criteria

1) Patients with head and neck cancer.
2) Patients with a history of laryngectomy.
3) Patients with a history of radiotherapy for pharyngolaryngeal region.
4) Patients who have already enrolled in the study.

Target sample size

550


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yano Tomonori

Organization

National Cancer Center Hospital East, Kashiwa, Japan

Division name

Department of Gastroenterology, Endoscopy division

Zip code


Address

Kashiwanoha 6-5-1, Kashiwa, Chiba, Japan

TEL

04-7133-1111

Email

toyano@east.ncc.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Morimoto

Organization

National Cancer Center Hospital East, Kashiwa, Japan

Division name

Department of Gastroenterology, Endoscopy division

Zip code


Address

Kashiwanoha 6-5-1, Kashiwa, Chiba, Japan

TEL

04-7133-1111

Homepage URL


Email

hmorimot@east.ncc.go.jp


Sponsor or person

Institute

National Cancer Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター東病院(千葉県)、千葉県がんセンター(千葉県)、東京女子医科大学八千代医療センター(千葉県)、総合病院国保旭中央病院(千葉県)、東京歯科大学市川総合病院(千葉県)、千葉労災病院(千葉県)、東邦大学医療センター佐倉病院(千葉県)、千葉市立海浜病院(千葉県)、化学療法研究所附属病院(千葉県)、千葉西総合病院(千葉県)、亀田総合病院(千葉県)、千葉大学医学部附属病院(千葉県)、東京慈恵会医科大学附属柏病院(千葉県)、帝京大学ちば総合医療センター(千葉県)、千葉徳洲会病院(千葉県)、新東京病院(千葉県)、順天堂大学医学部附属浦安病院(千葉県)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2014 Year 11 Month 19 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A multicenter prospective observational study


Management information

Registered date

2015 Year 05 Month 08 Day

Last modified on

2015 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020071